✦ LIBER ✦
4103 ORAL Doxorubicin Can Be Safely Omitted From the Treatment of Stage ll/lll, Intermediate Risk Histology Wilms Tumour – Results of the SIOP WT 2001 Randomised Trial, on Behalf of the SIOP Renal Tumours Study Group
✍ Scribed by Pritchard-Jones, K.; Graf, N.; Bergeron, C.; de Camargo, B.; van den Heuvel, M.; Sandstedt, B.; Godzinski, J.; Oldenburger, F.; van Tinteren, H.; de Kraker, J.
- Book ID
- 122976157
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 59 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.